4884 Kringle Pharma,Inc.クリングルファーマTSE Growth / Pharmaceuticals
0 posts
Kringle Pharma,Inc. stock rose on Nov 19: what happened
It closed at ¥575 on Nov 19 (+¥50.0, +9.52%), ranking #16 among the top gainers of all stocks on the Tokyo Stock Exchange.
No disclosures were found for this stock around that day. Share what you know in the posts below.
Changes are calculated from the closing prices this site collects daily; limit-up/down is an estimate based on the daily price limit. Please make your own investment decisions.
Kringle Pharma,Inc. (4884) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Kringle Pharma,Inc. (4884) Stock Price History
Kringle Pharma,Inc. closed at ¥541 on Nov 20, 2026, −8.9% over 1 month, +31.0% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥91,077 today (−8.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −8.9%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥541 | −34 | −5.91% |
| Nov 19 (Thu) | ¥575 | +50 | +9.52% |
| Nov 18 (Wed) | ¥525 | −49 | −8.54% |
| Nov 17 (Tue) | ¥574 | +45 | +8.51% |
| Nov 16 (Mon) | ¥529 | −28 | −5.03% |
| Nov 13 (Fri) | ¥557 | +38 | +7.32% |
| Nov 12 (Thu) | ¥519 | −2 | −0.38% |
| Nov 11 (Wed) | ¥521 | +2 | +0.39% |
| Nov 10 (Tue) | ¥519 | +23 | +4.64% |
| Nov 9 (Mon) | ¥496 | +20 | +4.20% |
If you had invested ¥100,000 3 months ago, it would be worth ¥121,573 today (+21.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved +21.6%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥541 | −34 | −5.91% |
| Nov 19 (Thu) | ¥575 | +50 | +9.52% |
| Nov 18 (Wed) | ¥525 | −49 | −8.54% |
| Nov 17 (Tue) | ¥574 | +45 | +8.51% |
| Nov 16 (Mon) | ¥529 | −28 | −5.03% |
| Nov 13 (Fri) | ¥557 | +38 | +7.32% |
| Nov 12 (Thu) | ¥519 | −2 | −0.38% |
| Nov 11 (Wed) | ¥521 | +2 | +0.39% |
| Nov 10 (Tue) | ¥519 | +23 | +4.64% |
| Nov 9 (Mon) | ¥496 | +20 | +4.20% |
If you had invested ¥100,000 6 months ago, it would be worth ¥132,598 today (+32.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved +32.6%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥541 | −3.2% |
| Oct 2026 | ¥559 | +11.6% |
| Sep 2026 | ¥501 | +13.3% |
| Aug 2026 | ¥442 | +36.4% |
| Jul 2026 | ¥324 | −2.1% |
| Jun 2026 | ¥331 | −15.8% |
| May 2026 | ¥393 | −14.8% |
If you had invested ¥100,000 1 year ago, it would be worth ¥130,993 today (+31.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved +31.0%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥541 | −3.2% |
| Oct 2026 | ¥559 | +11.6% |
| Sep 2026 | ¥501 | +13.3% |
| Aug 2026 | ¥442 | +36.4% |
| Jul 2026 | ¥324 | −2.1% |
| Jun 2026 | ¥331 | −15.8% |
| May 2026 | ¥393 | −14.8% |
| Apr 2026 | ¥461 | +13.3% |
| Mar 2026 | ¥407 | +3.0% |
| Feb 2026 | ¥395 | +1.0% |
| Jan 2026 | ¥391 | +0.5% |
| Dec 2025 | ¥389 | −6.7% |
| Nov 2025 | ¥417 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥69,806 today (−30.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −30.2%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥541 | +39.1% |
| 2025 | ¥389 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥86,977 today (−13.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −13.0%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥541 | +39.1% |
| 2025 | ¥389 | ― |
If you had invested ¥100,000 in Dec 2020, it would be worth ¥40,830 today (−59.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +105.6%, while this stock moved −59.2%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥541 | +39.1% |
| 2025 | ¥389 | −55.4% |
| 2024 | ¥873 | +16.1% |
| 2023 | ¥752 | +31.5% |
| 2022 | ¥572 | −15.9% |
| 2021 | ¥680 | −48.7% |
| 2020 | ¥1,325 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Dec 2020). Please check the latest prices before trading.
Kringle Pharma,Inc. (4884) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of Kringle Pharma,Inc. (4884)
Business overview
The company is a university-born biotech developing drugs for intractable diseases. It is working to turn HGF (hepatocyte growth factor) protein, discovered at Osaka University, into a medicine, and a clinical trial in acute spinal cord injury produced results suggesting efficacy. Rather than handing development to a drug maker, it aims to obtain marketing approval itself, and its pipeline also covers vocal fold scarring, ALS and acute kidney injury.
Summarized from the annual securities report (fiscal year ended September 2025) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| PBR | 4.12x | Above the sector median of 1.86x (No. 63 from the lowest) |
|---|---|---|
| ROE | -157.20% | No. 52 in the sector (highest first); median 4.17% |
| Market cap | ¥4.6 bn | No. 67 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥696 | 10/13 |
|---|---|---|
| 52-week low | ¥296 | 6/15 |
| Current position | 61.3% | Where the low is 0% and the high is 100% (close on 11/20: ¥541) |
| Year to date | +39.1% | No. 7 of 77 in the sector (best first) |
| 1 year | +31.0% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 6 times | Latest: 11/19 (No. 16) |
|---|---|---|
| Top 50 losers | 4 times | Latest: 11/18 (No. 14) |
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/18 16:50第三者割当による株式、第19回新株予約権及び第20回新株予約権(行使価額修正条項選択権付)の発行条件等の決定に関するお知らせ
- 11/18 16:50定時株主総会の付議議案に関するお知らせ
- 11/17 17:302026年9月期 通期決算説明会 質疑応答について
- 11/13 16:002026年9月期 通期決算説明会資料
- 11/11 15:502026年9月期決算短信〔日本基準〕(非連結)
- 11/11 15:50第三者割当による株式、第19回新株予約権及び第20回新株予約権(行使価額修正条項選択権付)の発行、並びに新株予約権買取契約の締結に関するお知らせ
- 11/11 15:50資金調達に関する補足説明資料
- 10/19 10:45脊髄損傷急性期を対象とするoremepermin alfaの米国FDAにおけるIND発効のお知らせ
- 09/24 09:00脊髄損傷急性期を対象とするoremepermin alfaの米国FDAに対するIND(新薬治験開始)申請のお知らせ
- 09/16 17:302026年9月期業績予想の修正に関するお知らせ
Filings from the past 12 months (10).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the Kringle Pharma,Inc. board
More Japanese stocks in English
- MUROMACHI CHEMICALS INC.4885
- ASKA Pharmaceutical Holdings Co.,Ltd.4886
- SAWAI GROUP HOLDINGS Co.,Ltd.4887
- STELLA PHARMA CORPORATION4888
- Renascience Inc.4889
- iShares Yen Appreciation Focus ETF488A
- Tsubota Laboratory Incorporated4890
- TMS Co.,Ltd.4891
- Cyfuse Biomedical K.K.4892
- Noile-Immune Biotech Inc.4893
- Cuorips Inc.4894
- K Pharma,Inc.4896